Omnicell Investor Presentation Deck slide image

Omnicell Investor Presentation Deck

Convertible senior notes, net Cash and cash equivalents Net debt Net debt/Non-GAAP EBITDA Long-term debt, current portion, net Long-term debt, net Total debt, net Cash and cash equivalents Net debt Net debt/Non-GAAP EBITDA (a) © 2023 Omnicell, Inc. (a) Quarter Ended June 30, 2023 $ $ $ Omnicell, Inc. Reconciliation of GAAP to Non-GAAP (Unaudited, in thousands, except per share data and percentage) $ Year Ended December 31, $ 568,114 (399,464) 168,650 2017 1.1 15,208 194,917 210,125 (32,424) 177,701 1.9 (a) Net Debt / EBITDA = (Total Debt - Cash and Cash Equivalents) / Trailing Twelve Months Non-GAAP EBITDA Revolver availability Cash and cash equivalents Liquidity Revolver availability Cash and cash equivalents Liquidity Quarter Ended June 30, 2023 $ $ Year Ended December 31, 2017 $ 417,687 399,464 817,151 $ 280,500 32,424 312,924 26
View entire presentation